Guardant Health (GH) Competitors

Guardant Health (NASDAQ:GH) and Veracyte (NASDAQ:VCYT) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

Which has preferable earnings & valuation, GH or VCYT?

Veracyte has lower revenue, but higher earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$739.02M	10.36	-$436.37M	-$3.35	-18.33
Veracyte	$479.13M	5.09	$24.14M	$0.33	93.94

Do analysts rate GH or VCYT?

Guardant Health currently has a consensus price target of $57.50, suggesting a potential downside of 6.35%. Veracyte has a consensus price target of $40.90, suggesting a potential upside of 31.94%. Given Veracyte's higher probable upside, analysts clearly believe Veracyte is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	3.06
Veracyte	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70

Is GH or VCYT more profitable?

Veracyte has a net margin of 5.50% compared to Guardant Health's net margin of -49.93%. Veracyte's return on equity of 6.07% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-49.93%	N/A	-28.95%
Veracyte	5.50%	6.07%	5.53%

Does the media favor GH or VCYT?

In the previous week, Guardant Health had 1 more articles in the media than Veracyte. MarketBeat recorded 10 mentions for Guardant Health and 9 mentions for Veracyte. Veracyte's average media sentiment score of 1.15 beat Guardant Health's score of 1.11 indicating that Veracyte is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Veracyte	6 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of GH or VCYT?

92.6% of Guardant Health shares are owned by institutional investors. 6.1% of Guardant Health shares are owned by insiders. Comparatively, 1.4% of Veracyte shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Which has more volatility and risk, GH or VCYT?

Guardant Health has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Veracyte has a beta of 1.97, suggesting that its share price is 97% more volatile than the S&P 500.

Summary

Veracyte beats Guardant Health on 9 of the 17 factors compared between the two stocks.